Category: Abu Dhabi

  • Sinopharm launches Phase III trial of inactivated-virus vaccine in Abu Dhabi

    The Beijing company said it selected the United Arab Emirates because of its ethnic diversity, which will enable it to determine the feasibility of taking its program global. It claims that its study is the first Phase III inactivated vaccine trial, but another Chinese firm has also launched one in Brazil.